| 2026 |
| 05/13 | 2,812 | 3,011 | 2,747 | 2,978 | -6.09% | 6,495,900 | 2兆6493億 | -8.73% |
| 05/12 | （IR情報）15:30 2025年度決算説明資料 |
| 05/12 | （IR情報）15:30 2026年3月期決算補足資料 |
| 05/12 | （IR情報）15:30 2026年3月期決算短信〔IFRS〕(連結) |
| 05/12 | 3,188 | 3,235 | 3,165 | 3,171 | -1.12% | 2,385,000 | 2兆8210億 | -3.5% |
| 05/11 | （5%ルール）ウエリントン・マネージメント・カンパニー・エルエ…（3.68%）ウエリントン・マネージメント・ジャパン・ピーティ…（0.69%）ウエリントン・マネージメント・ホンコン・リミテッ…（0.45%）ウエリントン・マネージメント・ヨーロッパ・ゲーエ…（0.4%） |
| 05/11 | 3,177 | 3,216 | 3,137 | 3,207 | +0.94% | 3,007,600 | 2兆8530億 | -2.94% |
| 05/08 | 3,221 | 3,222 | 3,156 | 3,177 | +0.83% | 3,477,400 | 2兆8263億 | -4.16% |
| 05/07 | 3,128 | 3,195 | 3,100 | 3,151 | +0.74% | 3,455,600 | 2兆8032億 | -5.29% |
| 05/01 | 3,172 | 3,174 | 3,112 | 3,128 | -1.32% | 2,327,800 | 2兆7827億 | -6.4% |
| 04/30 | 3,157 | 3,175 | 3,102 | 3,170 | -0.31% | 4,783,900 | 2兆8201億 | -5.51% |
| 04/28 | 3,145 | 3,180 | 3,070 | 3,180 | +3.41% | 3,540,100 | 2兆8290億 | -5.53% |
| 04/27 | （IR情報）17:00 当社の完全子会社である鳥居薬品株式会社の吸収合併(簡易合併・略式合併)に関するお知らせ |
| 04/27 | （IR情報）15:15 2026年3月期配当予想の修正(増配)に関するお知らせ |
| 04/27 | 3,096 | 3,123 | 3,030 | 3,075 | -1.13% | 2,405,000 | 2兆7356億 | -8.78% |
| 04/24 | 3,080 | 3,117 | 3,074 | 3,110 | +0.52% | 2,284,800 | 2兆7667億 | -7.96% |
| 04/23 | 3,082 | 3,109 | 3,055 | 3,094 | +0.26% | 2,727,100 | 2兆7525億 | -8.7% |
| 04/22 | 3,120 | 3,123 | 3,047 | 3,086 | -1.34% | 2,403,400 | 2兆7454億 | -9.37% |
| 04/21 | 3,191 | 3,200 | 3,115 | 3,128 | -2.65% | 2,389,200 | 2兆7827億 | -8.56% |
| 04/20 | 3,259 | 3,259 | 3,198 | 3,213 | -0.22% | 2,020,600 | 2兆8583億 | -6.38% |
| 04/17 | 3,262 | 3,275 | 3,215 | 3,220 | -1.71% | 2,315,500 | 2兆8646億 | -6.4% |
| 04/16 | 3,301 | 3,328 | 3,263 | 3,276 | -0.7% | 2,930,300 | 2兆9144億 | -4.96% |
| 04/15 | 3,323 | 3,350 | 3,287 | 3,299 | -0.84% | 2,399,600 | 2兆9348億 | -4.52% |
| 04/14 | 3,377 | 3,399 | 3,327 | 3,327 | -1.42% | 1,808,800 | 2兆9598億 | -3.87% |
| 04/13 | 3,375 | 3,406 | 3,351 | 3,375 | +0.12% | 2,094,100 | 3兆25億 | -2.54% |
| 04/10 | 3,408 | 3,475 | 3,340 | 3,371 | -3.08% | 3,792,900 | 2兆9989億 | -2.74% |
| 04/09 | 3,536 | 3,573 | 3,478 | 3,478 | -3.55% | 3,298,400 | 3兆941億 | +0.26% |
| 04/08 | 3,758 | 3,758 | 3,600 | 3,606 | -0.33% | 3,499,500 | 3兆2080億 | +4.01% |
| 04/07 | 3,582 | 3,618 | 3,563 | 3,618 | +1.06% | 1,768,500 | 3兆2186億 | +4.51% |
| 04/06 | 3,554 | 3,616 | 3,545 | 3,580 | +0.51% | 1,347,300 | 3兆1848億 | +3.47% |
| 04/03 | 3,550 | 3,575 | 3,533 | 3,562 | +0.51% | 1,325,300 | 3兆1688億 | +2.86% |
| 04/02 | 3,667 | 3,670 | 3,541 | 3,544 | -2.29% | 2,485,600 | 3兆1528億 | +2.25% |
| 04/02 | （IR情報）8:30 エダラボン事業の承継完了およびRadicava事業会社設立に関するお知らせ |
| 04/01 | （IR情報）15:00 ViiV Healthcare Ltd.の株式取得完了について |
| 04/01 | 3,539 | 3,627 | 3,509 | 3,627 | +4.55% | 3,259,800 | 3兆2266億 | +4.49% |
| 03/31 | 3,460 | 3,534 | 3,446 | 3,469 | -0.66% | 4,554,600 | 3兆861億 | -0.06% |
| 03/30 | 3,412 | 3,494 | 3,361 | 3,492 | -0.65% | 3,560,100 | 3兆1065億 | +0.4% |
| 03/27 | （IR情報）15:30 ViiV Healthcare Ltd.への追加出資に係るブリッジローン契約の締結について |
| 03/27 | 3,476 | 3,515 | 3,450 | 3,515 | +1.68% | 3,784,400 | 3兆1270億 | +0.89% |
| 03/26 | 3,430 | 3,484 | 3,430 | 3,457 | +0.46% | 2,459,800 | 3兆754億 | -0.86% |
| 03/25 | 3,433 | 3,457 | 3,403 | 3,441 | +3.68% | 2,576,600 | 3兆612億 | -1.35% |
| 03/24 | 3,265 | 3,327 | 3,260 | 3,319 | +1.93% | 2,694,500 | 2兆9526億 | -4.85% |
| 03/24 | （IR情報）8:30 Shionogi-Apnimed Sleep Science, LLCの連結子会社化に関するお知らせ |
| 03/23 | （IR情報）16:00 田辺ファーマからの筋萎縮性側索硬化症等治療薬エダラボン事業の買収に係るブリッジローンの借入について |
| 03/23 | （IR情報）15:00 抗新型コロナウイルス(SARS-CoV-2)薬ゾコーバの日本における新型コロナウイルス感染症(COVID-19)予防に関する効能・効果追加承認について |
| 03/23 | 3,242 | 3,282 | 3,222 | 3,256 | -3.3% | 3,313,500 | 2兆8966億 | -6.89% |
| 03/19 | 3,406 | 3,431 | 3,346 | 3,367 | -4.05% | 4,682,500 | 2兆9953億 | -4.02% |
| 03/18 | 3,469 | 3,509 | 3,430 | 3,509 | +1.01% | 2,053,700 | 3兆1217億 | -0.11% |
| 03/17 | 3,447 | 3,515 | 3,444 | 3,474 | +1.88% | 2,455,000 | 3兆905億 | -1.11% |
| 03/16 | 3,363 | 3,436 | 3,353 | 3,410 | +0.03% | 2,280,200 | 3兆336億 | -2.85% |
| 03/13 | 3,358 | 3,442 | 3,358 | 3,409 | +0.15% | 2,664,700 | 3兆327億 | -2.91% |
| 03/12 | 3,393 | 3,425 | 3,360 | 3,404 | -1.59% | 2,588,400 | 3兆283億 | -2.99% |
| 03/11 | 3,500 | 3,533 | 3,439 | 3,459 | +0.26% | 2,047,300 | 3兆772億 | -1.37% |
| 03/10 | 3,459 | 3,482 | 3,417 | 3,450 | +1.8% | 2,510,600 | 3兆692億 | -1.34% |
| 03/09 | 3,300 | 3,407 | 3,300 | 3,389 | -1.8% | 2,564,500 | 3兆149億 | -2.78% |
| 03/06 | 3,319 | 3,451 | 3,318 | 3,451 | +0.32% | 2,233,700 | 3兆701億 | -0.69% |
| 03/05 | 3,493 | 3,515 | 3,425 | 3,440 | +0.64% | 2,574,700 | 3兆603億 | -0.61% |
| 03/04 | 3,445 | 3,470 | 3,389 | 3,418 | -2.26% | 2,654,800 | 3兆407億 | -0.9% |
| 03/03 | 3,485 | 3,543 | 3,464 | 3,497 | -1.58% | 2,337,500 | 3兆1110億 | +1.75% |
| 03/02 | 3,624 | 3,635 | 3,528 | 3,553 | -3.03% | 2,588,000 | 3兆1608億 | +3.8% |
| 02/27 | （IR情報）13:00 アトピー性皮膚炎治療薬「コレクチム」の国内におけるローション剤の剤形追加に関する製造販売承認申請について |
| 02/27 | 3,644 | 3,687 | 3,616 | 3,664 | +0.44% | 4,718,500 | 3兆2596億 | +7.7% |
| 02/26 | 3,657 | 3,667 | 3,623 | 3,648 | -0.44% | 2,364,500 | 3兆2453億 | +8.22% |
| 02/25 | 3,700 | 3,705 | 3,625 | 3,664 | +0.94% | 2,733,300 | 3兆2596億 | +9.63% |
| 02/24 | 3,666 | 3,666 | 3,574 | 3,630 | -0.41% | 2,844,300 | 3兆2293億 | +9.7% |
| 02/20 | （IR情報）16:30 当社の完全子会社である鳥居薬品株式会社の吸収合併に関する基本方針決定のお知らせ |
| 02/20 | 3,602 | 3,678 | 3,601 | 3,645 | +0.08% | 1,951,700 | 3兆2427億 | +11.16% |
| 02/19 | 3,535 | 3,660 | 3,523 | 3,642 | +1.87% | 2,427,000 | 3兆2400億 | +12.06% |
| 02/18 | 3,512 | 3,577 | 3,506 | 3,575 | +2.82% | 1,814,500 | 3兆1804億 | +10.96% |
| 02/17 | 3,471 | 3,505 | 3,452 | 3,477 | +0.78% | 1,649,700 | 3兆932億 | +8.83% |
| 02/16 | 3,577 | 3,577 | 3,450 | 3,450 | -2.43% | 2,171,800 | 3兆692億 | +8.76% |
| 02/13 | 3,579 | 3,588 | 3,484 | 3,536 | +0.03% | 4,530,400 | 3兆1457億 | +12.22% |
| 02/12 | 3,539 | 3,540 | 3,497 | 3,535 | +1.17% | 2,810,600 | 3兆1448億 | +13.16% |
| 02/10 | 3,527 | 3,560 | 3,494 | 3,494 | -0.77% | 2,783,800 | 3兆1083億 | +12.86% |
| 02/09 | 3,581 | 3,591 | 3,496 | 3,521 | +3.77% | 3,530,800 | 3兆1323億 | +14.65% |
| 02/06 | 3,405 | 3,428 | 3,356 | 3,393 | -1.02% | 2,540,900 | 3兆185億 | +11.47% |
| 02/05 | 3,558 | 3,558 | 3,427 | 3,428 | +1.63% | 3,553,100 | 3兆496億 | +13.47% |
| 02/04 | 3,350 | 3,392 | 3,302 | 3,373 | +0.81% | 2,609,300 | 3兆7億 | +12.51% |
| 02/03 | 3,287 | 3,363 | 3,240 | 3,346 | +4.01% | 3,944,200 | 2兆9767億 | +12.36% |
| 02/02 | 3,291 | 3,291 | 3,217 | 3,217 | +1.35% | 3,162,600 | 2兆8619億 | +8.87% |
| 01/30 | （IR情報）13:00 2026年3月期第3四半期決算〈補足資料) |
| 01/30 | （IR情報）13:00 2025年度第3四半期決算説明資料 |
| 01/30 | （IR情報）13:00 2026年3月期第3四半期決算短信〔IFRS〕(連結) |
| 01/30 | 3,088 | 3,247 | 3,076 | 3,174 | +1.86% | 5,297,000 | 2兆8236億 | +8.03% |
| 01/29 | 3,022 | 3,132 | 3,021 | 3,116 | +1.23% | 3,255,000 | 2兆7720億 | +6.75% |
| 01/28 | 3,092 | 3,138 | 3,078 | 3,078 | -2.29% | 4,420,200 | 2兆7382億 | +6.03% |
| 01/27 | 3,082 | 3,156 | 3,040 | 3,150 | +1.22% | 3,161,800 | 2兆8023億 | +9.03% |
| 01/26 | 3,040 | 3,118 | 3,032 | 3,112 | -1.21% | 4,026,500 | 2兆7685億 | +8.36% |
| 01/23 | 3,051 | 3,150 | 3,033 | 3,150 | +4.13% | 5,044,500 | 2兆8023億 | +10.22% |
| 01/22 | 2,942 | 3,029 | 2,924 | 3,025 | +4.24% | 4,656,500 | 2兆6911億 | +6.44% |
| 01/21 | 2,851 | 2,902 | 2,825 | 2,902 | -0.65% | 3,812,500 | 2兆5817億 | +2.62% |
| 01/20 | 2,925 | 2,949 | 2,860 | 2,921 | +2.82% | 4,123,200 | 2兆5986億 | +3.66% |
| 01/20 | （IR情報）8:30 ViiV Healthcare Ltd.への追加出資による持分法適用関連会社化について |
| 01/19 | 2,850 | 2,860 | 2,828 | 2,841 | -0.77% | 1,683,100 | 2兆5274億 | +1.14% |
| 01/16 | 2,863 | 2,880 | 2,814 | 2,863 | -2.55% | 2,615,000 | 2兆5470億 | +2% |
| 01/15 | 2,969 | 2,983 | 2,926 | 2,938 | -0.14% | 2,512,400 | 2兆6137億 | +4.93% |
| 01/14 | 2,930 | 2,956 | 2,907 | 2,942 | +1.59% | 3,081,800 | 2兆6172億 | +5.49% |
| 01/13 | 2,934 | 2,959 | 2,896 | 2,896 | -0.38% | 3,334,800 | 2兆5763億 | +4.21% |
| 01/09 | 2,909 | 2,918 | 2,867 | 2,907 | -0.62% | 3,729,500 | 2兆5861億 | +5.02% |
| 01/08 | 2,908 | 2,955 | 2,901 | 2,925 | +2.88% | 3,370,500 | 2兆6021億 | +6.06% |
| 01/07 | 2,819 | 2,862 | 2,801 | 2,843 | -0.14% | 3,232,900 | 2兆5292億 | +3.57% |
| 01/06 | 2,852 | 2,867 | 2,839 | 2,847 | -0.63% | 3,261,300 | 2兆5327億 | +3.94% |
| 01/05 | 2,860 | 2,882 | 2,837 | 2,865 | +0.84% | 2,430,000 | 2兆5487億 | +4.83% |
| 2025 |
| 12/30 | 2,832 | 2,844 | 2,822 | 2,841 | +0.28% | 2,200,100 | 2兆5274億 | +4.1% |
| 12/29 | 2,825 | 2,853 | 2,816 | 2,833 | -0.56% | 1,991,500 | 2兆5203億 | +4% |
| 12/26 | 2,870 | 2,884 | 2,833 | 2,849 | -0.35% | 1,943,800 | 2兆5345億 | +4.78% |
| 12/25 | 2,820 | 2,859 | 2,797 | 2,859 | +2.99% | 1,678,800 | 2兆5434億 | +5.34% |
| 12/24 | 2,800 | 2,822 | 2,770 | 2,776 | -0.47% | 2,481,300 | 2兆4696億 | +2.55% |
| 12/23 | 2,740 | 2,795 | 2,733 | 2,789 | +3.11% | 2,808,000 | 2兆4811億 | +3.14% |
| 12/22 | （IR情報）19:00 田辺ファーマからの筋萎縮性側索硬化症等治療薬エダラボン事業の買収に関するお知らせ |
| 12/22 | （IR情報）15:00 うつ病治療薬「ザズベイカプセル30mg」の国内における製造販売承認取得について |
| 12/22 | 2,720 | 2,728 | 2,677 | 2,705 | -0.41% | 1,533,100 | 2兆4064億 | +0.19% |
| 12/19 | 2,735 | 2,736 | 2,708 | 2,716 | -0.84% | 4,115,100 | 2兆4162億 | +0.56% |
| 12/18 | 2,734 | 2,763 | 2,726 | 2,739 | +0.74% | 1,749,300 | 2兆4367億 | +1.37% |
| 12/17 | 2,723 | 2,731 | 2,700 | 2,719 | -1.63% | 2,181,600 | 2兆4189億 | +0.7% |
| 12/16 | 2,742 | 2,785 | 2,740 | 2,764 | +0.8% | 2,493,000 | 2兆4589億 | +2.48% |
| 12/15 | 2,693 | 2,754 | 2,687 | 2,742 | +2.43% | 2,505,900 | 2兆4393億 | +1.86% |
| 12/12 | 2,664 | 2,699 | 2,662 | 2,677 | +0.6% | 3,551,400 | 2兆3815億 | -0.37% |
| 12/11 | 2,674 | 2,676 | 2,651 | 2,661 | -0.63% | 2,305,200 | 2兆3673億 | -0.89% |
| 12/10 | 2,725 | 2,774 | 2,678 | 2,678 | -4.66% | 4,520,600 | 2兆3824億 | -0.15% |
10年以上蓄積したファイナンスデータとAIを掛け合わせて、投資の意思決定を加速させるポジションです。
